FLGT News and Press, Fulgent Genetics Inc. From 02/28/24

A look at the top 10 most actives in the United States Marathon Digital Holdings Inc. (MARA) rose 1.8% to $30.87 on volume of 148,760,969 shares Vivani Medical Inc. (VANI) rose 291.9% to $3.9579 on volume of 141,227,838 shares Nikola Corporation (NKLA) rose 2.6% to $0.7758 on volume of 10...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

2024-02-21 07:20:23 ET Summary Fulgent Genetics spent the past 2 years digesting the Covid cliff, which wiped out 80% of its market capitalization since the 2021 peak. The company is about to hit an inflection point, as 2024 will be the year revenues return to growth while margins...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its fourth quarter and full year 2023 financ...

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing PR Newswire Testing offers CBR families the opportunity to proactively seek additional information about their child's health ‍TRUMBULL, Conn. an...

2024-01-18 20:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-08 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-01 13:00:48 ET Summary Fulgent Genetics, Inc. is a diagnostic company that is currently navigating through a significant decline in revenues as the pandemic ends. However, its "core" business is growing nicely, and the stock trades for just under the net cash on its balanc...

2023-11-25 09:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re searching for digital health stocks to add to your portfolio, look no further. Technological innovation is leading to the increased digitalization and personalization of health...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate ...